Skip to main content

Home/ Nutrition/ Group items tagged immunomodulation

Rss Feed Group items tagged

Matti Narkia

Immunomodulation by omega-3 fatty acids - Prostaglandins Leukot Essent Fatty Acids. 200... - 0 views

  •  
    Immunomodulation by omega-3 fatty acids. Calder PC. Prostaglandins Leukot Essent Fatty Acids. 2007 Nov-Dec;77(5-6):327-35. Epub 2007 Nov 26. Review. PMID: 18032006 doi:10.1016/j.plefa.2007.10.015
Matti Narkia

Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease - ... - 0 views

  •  
    Differential immunomodulation with long-chain n-3 PUFA in health and chronic disease. Sijben JW, Calder PC. Proc Nutr Soc. 2007 May;66(2):237-59. Review. PMID: 17466105 doi:10.1017/S0029665107005472
Matti Narkia

Vitamin D -- Dusso et al. 289 (1): F8 -- AJP - Renal Physiology - 0 views

  •  
    Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28. Review. PMID: 15951480 [PubMed - indexed for MEDLINE]
Matti Narkia

Luteolin - Wikipedia, the free encyclopedia - 0 views

  •  
    Luteolin is a flavonoid and more specifically a flavone. It is thought to play an important role in the human body as an antioxidant, a free radical scavenger, an agent in the prevention of inflammation, a promoter of carbohydrate metabolism, and an immun
Matti Narkia

Perioperative immunonutrition in head and neck cancer. - Wiley InterScience :: JOURNALS... - 0 views

  •  
    Perioperative immunonutrition in head and neck cancer. Sorensen LD, McCarthy M, Baumgartner MB, Demars CS. Laryngoscope. 2009 May 20. [Epub ahead of print] PMID: 19459146 DOI: 10.1002/lary.20494
Matti Narkia

Vitamin D treatment in multiple sclerosis - ScienceDirect - Journal of the Neurological... - 0 views

  •  
    Vitamin D treatment in multiple sclerosis. Myhr KM. J Neurol Sci. 2009 Jun 22. [Epub ahead of print] PMID: 19549608 doi:10.1016/j.jns.2009.05.002 Epidemiological evidence combined with clinical and laboratory analyses, and experimental animal models, suggest a possible influence of vitamin D on MS susceptibility as well as clinical disease activity. Supplement with vitamin D may reduce the risk of developing MS. An intervention may also reduce the risk of conversion from a first clinical event suggestive of MS to clinical definite MS, as well as reduce the relapse rate among patients with relapsing remitting MS. More studies are, however, needed to determine optimal dose and serum level for vitamin D, as well as target populations and optimal timing for intervention.
Matti Narkia

Vitamin D and autoimmune rheumatic diseases -- Cutolo 48 (3): 210 -- Rheumatology - 0 views

  •  
    Vitamin D and autoimmune rheumatic diseases. Cutolo M. Rheumatology (Oxford). 2009 Mar;48(3):210-2. Epub 2008 Oct 17. PMID: 18930963 doi:10.1093/rheumatology/ken394
Matti Narkia

Oral Probiotic Control Skin Inflammation by Acting on Both Effector and Regulatory T Ce... - 0 views

  •  
    Oral probiotic control skin inflammation by acting on both effector and regulatory T cells. Hacini-Rachinel F, Gheit H, Le Luduec JB, Dif F, Nancey S, Kaiserlian D. PLoS ONE. 2009;4(3):e4903. Epub 2009 Mar 20. PMID: 19300508 doi:10.1371/journal.pone.0004903
1 - 8 of 8
Showing 20 items per page